Virosome Expertise Capitalize on Mymetics’ core virosome technology and its focus on next-generation preventative vaccines to position advisory or collaboration opportunities around platform partnerships, contract research, and co-development programs with vaccine developers seeking advanced delivery systems.

Clinical & Academic Ties Target partnerships with Mymetics’ established collaborators (Astellas Pharma, PATH-MVI, Gates Foundation) to explore joint-funded research, grant opportunities, or advisory roles that can accelerate pipeline programs and provide access to influential networks.

Thermostable Vaccine Potential Leverage their history of thermostable, cold-chain independent vaccine development to propose opportunities with global health organizations and emerging markets that require robust storage solutions and reduced logistical barriers.

Covid-19 Antigen Platform Offer targeted outreach to vaccine developers and infectious disease programs seeking rapid antigen selection and virosome-based formulations, highlighting potential for safe, dose-sparing, and easy-to-administer candidates.

Strategic Partnerships Position as a partner for biotech funders and contract research groups given their collaborative track record, existing lab footprint in the Netherlands, and Swiss base, to pursue co-development, licensing, or sponsored research deals aligned with mid-size biotech budgets.